10-K Filing

AgEagle Aerial Systems Inc. CIK: 8504 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0001575705-22-000260`
Period End Date	20211231
Filing Date	20220412
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	uavs_10k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 56 Cash Flow Statement 87 Stockholders Equity 30

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$14.59M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$23.94M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$2.89M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	-	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventories, net	`InventoryNet`	$135.65K	USD	Point-in-time
Inventories, net	`InventoryNet`	$4.04M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Prepaid and other current assets	`PrepaidExpenseCurrent`	$1.29M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	58.64M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	75.31M	shares	Point-in-time
Prepaid and other current assets	`PrepaidExpenseCurrent`	$122.01K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	75.31M	shares	Point-in-time
Notes receivable	`NotesReceivableNet`	$600.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	58.64M	shares	Point-in-time
Notes receivable	`NotesReceivableNet`	$185.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$23.00M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$24.80M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$122.59K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$952.13K	USD	Point-in-time
Right of use asset	`OperatingLeaseRightOfUseAsset`	$257.36K	USD	Point-in-time
Right of use asset	`OperatingLeaseRightOfUseAsset`	$2.02M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$13.57M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$440.53K	USD	Point-in-time
Goodwill	`Goodwill`	$3.11M	USD	Point-in-time
Goodwill	`Goodwill`	$64.87M	USD	Point-in-time
Other assets	`OtherAssets`	-	USD	Point-in-time
Other assets	`OtherAssets`	$282.87K	USD	Point-in-time
Total assets	`Assets`	$104.68M	USD	Point-in-time
Total assets	`Assets`	$28.73M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$159.81K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.53M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesAndOtherLiabilities`	$1.90M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesAndOtherLiabilities`	$1.84M	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$971.14K	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$2.30K	USD	Point-in-time
Current portion of liabilities related to acquisition agreements	`CurrentPortionOfLiabilityRelatedToAcquisitionAgreement`	-	USD	Point-in-time
Current portion of liabilities related to acquisition agreements	`CurrentPortionOfLiabilityRelatedToAcquisitionAgreement`	$10.06M	USD	Point-in-time
Current portion of lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.24M	USD	Point-in-time
Current portion of lease liabilities	`OperatingLeaseLiabilityCurrent`	$85.89K	USD	Point-in-time
Current portion of COVID loans	`CurrentPortionOfCovidLoan`	$451.89K	USD	Point-in-time
Current portion of COVID loans	`CurrentPortionOfCovidLoan`	$89.53K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.18M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$17.15M	USD	Point-in-time
Long term portion of liabilities related to acquisition agreements	`LongTermPortionOfLiabilitiesRelatedToAcquisitionAgreements`	-	USD	Point-in-time
Long term portion of liabilities related to acquisition agreements	`LongTermPortionOfLiabilitiesRelatedToAcquisitionAgreements`	$8.88M	USD	Point-in-time
Long term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$942.40K	USD	Point-in-time
Long term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$171.47K	USD	Point-in-time
Long term portion of COVID loans	`LongTermDebtNoncurrent`	$808.02K	USD	Point-in-time
Long term portion of COVID loans	`LongTermDebtNoncurrent`	$17.91K	USD	Point-in-time
Defined benefit plan obligation	`DefinedBenefitPlanBenefitObligation`	$331.73K	USD	Point-in-time
Defined benefit plan obligation	`DefinedBenefitPlanBenefitObligation`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$28.11M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.37M	USD	Point-in-time
Preferred Stock, $0.001 par value, 25,000,000 shares authorized, no shares issued and outstanding as of December 31, 2021 and 2020, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, $0.001 par value, 25,000,000 shares authorized, no shares issued and outstanding as of December 31, 2021 and 2020, respectively	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $0.001 par value, 250,000,000 shares authorized, 75,314,988 and 58,636,365 shares issued and outstanding as of December 31, 2021 and 2020, respectively	`CommonStockValue`	$75.31K	USD	Point-in-time
Common Stock, $0.001 par value, 250,000,000 shares authorized, 75,314,988 and 58,636,365 shares issued and outstanding as of December 31, 2021 and 2020, respectively	`CommonStockValue`	$58.64K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$127.63M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$47.24M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-20.95M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-51.05M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-70.59K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	-	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$26.35M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$76.58M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$4.27M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$104.68M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$28.73M	USD	Point-in-time

Income Statement 56 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	$9.76M	USD	Annual
Revenues	`Revenues`	$1.29M	USD	Annual
Cost of sales	`CostOfRevenue`	$5.50M	USD	Annual
Cost of sales	`CostOfRevenue`	$711.65K	USD	Annual
Gross Profit	`GrossProfit`	$573.73K	USD	Annual
Gross Profit	`GrossProfit`	$4.26M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$2.73M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$12.26M	USD	Annual
Professional fees	`ProfessionalFees`	$2.70M	USD	Annual
Professional fees	`ProfessionalFees`	$2.70M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$4.08M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$29.39K	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$3.15M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$40.00K	USD	Annual
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	Annual
Goodwill impairment	`GoodwillImpairmentLoss`	$12.36M	USD	Annual
Total Operating Expenses	`OperatingExpenses`	$34.55M	USD	Annual
Total Operating Expenses	`OperatingExpenses`	$5.51M	USD	Annual
Loss from Operations	`OperatingIncomeLoss`	$-4.93M	USD	Annual
Loss from Operations	`OperatingIncomeLoss`	$-30.29M	USD	Annual
Paycheck Protection Program loan forgiveness	`PaycheckProtectionProgramLoanForgiveness`	-	USD	Annual
Paycheck Protection Program loan forgiveness	`PaycheckProtectionProgramLoanForgiveness`	$108.53K	USD	Annual
Interest expense	`InterestExpense`	$549.00	USD	Annual
Interest expense	`InterestExpense`	$7.85K	USD	Annual
Loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-3.71K	USD	Annual
Loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-594.00	USD	Annual
Other income, net	`OtherNonoperatingIncomeExpense`	$87.12K	USD	Annual
Other income, net	`OtherNonoperatingIncomeExpense`	-	USD	Annual
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$-1.14K	USD	Annual
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$184.09K	USD	Annual
Loss Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-30.11M	USD	Annual
Loss Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-4.93M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Net Loss	`ProfitLoss`	$-30.11M	USD	Annual
Net Loss	`ProfitLoss`	$-4.93M	USD	Annual
Deemed dividends on Series C Preferred Stock and Series D warrants	`DeemedDividendOnSeriesCPreferredStockAndSeriesDWarrant`	$-4.05M	USD	Annual
Deemed dividends on Series C Preferred Stock and Series D warrants	`DeemedDividendOnSeriesCPreferredStockAndSeriesDWarrant`	-	USD	Annual
Deemed dividends on redemption of Series D Preferred Stock	`DeemedDividendOnRedemptionOfSeriesDPreferredStocks`	$-3.76M	USD	Annual
Deemed dividends on redemption of Series D Preferred Stock	`DeemedDividendOnRedemptionOfSeriesDPreferredStocks`	-	USD	Annual
Deemed dividends on issuance and repurchase of Series E Preferred Stock	`DeemedDividendOnIssuanceAndRepurchaseOfSeriesEPreferredStock`	$-1.23M	USD	Annual
Deemed dividends on issuance and repurchase of Series E Preferred Stock	`DeemedDividendOnIssuanceAndRepurchaseOfSeriesEPreferredStock`	-	USD	Annual
Series D Preferred stock dividends	`SeriesDPreferredStockDividends`	$69.78K	USD	Annual
Series D Preferred stock dividends	`SeriesDPreferredStockDividends`	-	USD	Annual
Net Loss Available to Common Stockholders	`NetLossAvailableToCommonStockholders`	$30.11M	USD	Annual
Net Loss Available to Common Stockholders	`NetLossAvailableToCommonStockholders`	$14.04M	USD	Annual
Defined benefit plan liability adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax`	$-67.90K	USD	Annual
Defined benefit plan liability adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax`	-	USD	Annual
Cumulative translation adjustment	`CumulativeTranslationAdjustment`	$-2.69K	USD	Annual
Cumulative translation adjustment	`CumulativeTranslationAdjustment`	-	USD	Annual
Total comprehensive loss, net of tax	`ComprehensiveIncomeNetOfTax`	$-30.18M	USD	Annual
Total comprehensive loss, net of tax	`ComprehensiveIncomeNetOfTax`	$-14.04M	USD	Annual
Net Loss Per Common Share - Basic and Diluted	`NetLossPercommonShareBasicAndDiluted`	$-0.35	USD	Annual
Net Loss Per Common Share - Basic and Diluted	`NetLossPercommonShareBasicAndDiluted`	$-0.43	USD	Annual
Weighted Average Number of Shares Outstanding During the Period -- Basic and Diluted	`WeightedAverageNumberOfSharesOutstandingDuringPeriodBasicAndDiluted`	40.69M	shares	Annual
Weighted Average Number of Shares Outstanding During the Period -- Basic and Diluted	`WeightedAverageNumberOfSharesOutstandingDuringPeriodBasicAndDiluted`	70.06M	shares	Annual

Cash Flow Statement 87 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$30.11M	USD	Annual
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-4.93M	USD	Annual
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	Annual
Goodwill impairment	`GoodwillImpairmentLoss`	$12.36M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$4.51M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$402.00K	USD	Annual
Common stock issued in exchange for professional services	`CommonStockIssuedInExchangeForProfessionalServices`	$2.91M	USD	Annual
Common stock issued in exchange for professional services	`CommonStockIssuedInExchangeForProfessionalServices`	$297.50K	USD	Annual
Depreciation, amortization	`Depreciation`	$173.66K	USD	Annual
Depreciation, amortization	`Depreciation`	$1.50M	USD	Annual
Provision for inventory obsolescence	`InventoryWriteDown`	-	USD	Annual
Provision for inventory obsolescence	`InventoryWriteDown`	$305.40K	USD	Annual
Defined benefit plan obligation and other	`DefinedBenefitPlanOtherChanges`	-	USD	Annual
Defined benefit plan obligation and other	`DefinedBenefitPlanOtherChanges`	$-17.69K	USD	Annual
Paycheck Protection Program loan forgiveness	`PaycheckProtectionProgramLoanForgivenes`	$108.53K	USD	Annual
Paycheck Protection Program loan forgiveness	`PaycheckProtectionProgramLoanForgivenes`	-	USD	Annual
Loss on disposal of fixed assets	`GainLossOnDispositionOfAssets`	$-3.71K	USD	Annual
Loss on disposal of fixed assets	`GainLossOnDispositionOfAssets`	$-594.00	USD	Annual
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-65.83K	USD	Annual
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-514.26K	USD	Annual
Inventories, net	`IncreaseDecreaseInInventories`	$-85.52K	USD	Annual
Inventories, net	`IncreaseDecreaseInInventories`	$1.98M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$218.49K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-2.15K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$102.38K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$552.74K	USD	Annual
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-2.89M	USD	Annual
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$1.81M	USD	Annual
Contract liabilities	`IncreaseDecreaseInContractWithCustomerLiability`	$393.52K	USD	Annual
Contract liabilities	`IncreaseDecreaseInContractWithCustomerLiability`	$-262.17K	USD	Annual
COVID loan	`IncreaseDecreaseInOtherLoans`	-	USD	Annual
COVID loan	`IncreaseDecreaseInOtherLoans`	$179.91K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-12.46M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.26M	USD	Annual
Issuance of notes receivable	`PaymentsToAcquireMortgageNotesReceivable`	-	USD	Annual
Issuance of notes receivable	`PaymentsToAcquireMortgageNotesReceivable`	$600.00K	USD	Annual
Payment on notes receivable	`PaymentOnNotesReceivable`	$-315.00K	USD	Annual
Purchases of fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$106.12K	USD	Annual
Purchases of fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$525.31K	USD	Annual
Acquisition of MicaSense, net of cash acquired	`AcquisitionOfMicasenseNetOfCashAcquired`	$14.57M	USD	Annual
Acquisition of MicaSense, net of cash acquired	`AcquisitionOfMicasenseNetOfCashAcquired`	-	USD	Annual
Acquisition of Measure, net of cash acquired	`AcquisitionOfMeasureNetOfCashAcquired`	-	USD	Annual
Acquisition of Measure, net of cash acquired	`AcquisitionOfMeasureNetOfCashAcquired`	$14.92M	USD	Annual
Acquisition of senseFly, net of cash acquired	`AcquisitionOfSenseflyNetOfCashAcquired`	$11.43M	USD	Annual
Acquisition of senseFly, net of cash acquired	`AcquisitionOfSenseflyNetOfCashAcquired`	-	USD	Annual
Platform development costs	`PlatformDevelopmentCosts`	$72.90K	USD	Annual
Platform development costs	`PlatformDevelopmentCosts`	$1.10M	USD	Annual
Internal use software costs	`PaymentsToDevelopSoftware`	-	USD	Annual
Internal use software costs	`PaymentsToDevelopSoftware`	$278.26K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-42.50M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-779.02K	USD	Annual
Proceeds from promissory note	`ProceedsFromNotesPayable`	-	USD	Annual
Proceeds from promissory note	`ProceedsFromNotesPayable`	$107.44K	USD	Annual
Issuance of Series E Preferred stock	`IssuanceOfSeriesEPreferredStock`	-	USD	Annual
Issuance of Series E Preferred stock	`IssuanceOfSeriesEPreferredStock`	$1.01M	USD	Annual
Repurchase of Series E Preferred stock	`RepurchaseOfSeriesEPreferredStock`	-	USD	Annual
Repurchase of Series E Preferred stock	`RepurchaseOfSeriesEPreferredStock`	$1.11M	USD	Annual
Sales of Common Stock, net of issuance costs	`SalesOfCommonStockNetOfIssuanceCost1`	$37.18M	USD	Annual
Sales of Common Stock, net of issuance costs	`SalesOfCommonStockNetOfIssuanceCost1`	$22.80M	USD	Annual
Sale of Common Stock from exercise of warrants	`ProceedsFromIssuanceOrSaleOfEquity`	$8.31M	USD	Annual
Sale of Common Stock from exercise of warrants	`ProceedsFromIssuanceOrSaleOfEquity`	$3.32M	USD	Annual
Exercise of stock options	`ProceedsFromStockOptionsExercised`	$122.97K	USD	Annual
Exercise of stock options	`ProceedsFromStockOptionsExercised`	$134.51K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$45.61M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$26.26M	USD	Annual
Net (decrease) increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-9.35M	USD	Annual
Net (decrease) increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$23.22M	USD	Annual
Cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$23.94M	USD	Point-in-time
Cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$14.59M	USD	Point-in-time
Cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$718.00K	USD	Point-in-time
Cash at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$23.94M	USD	Point-in-time
Cash at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$14.59M	USD	Point-in-time
Cash at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$718.00K	USD	Point-in-time
Interest cash paid	`InterestPaidNet`	-	USD	Annual
Interest cash paid	`InterestPaidNet`	-	USD	Annual
Income taxes paid	`IncomeTaxesPaid`	-	USD	Annual
Income taxes paid	`IncomeTaxesPaid`	-	USD	Annual
Conversion of Series C, D and E Preferred Stock into Common Stock	`ConversionOfSeriesBCDAndEPreferredStockIntoCommonStock`	-	USD	Annual
Conversion of Series C, D and E Preferred Stock into Common Stock	`ConversionOfSeriesBCDAndEPreferredStockIntoCommonStock`	$6.55K	USD	Annual
Issuance of Series E Preferred Stock	`IssuanceOfSeriesEPreferredStocks`	$1.05K	USD	Annual
Issuance of Series E Preferred Stock	`IssuanceOfSeriesEPreferredStocks`	-	USD	Annual
Deemed dividends	`DeemedDividends`	$9.11M	USD	Annual
Deemed dividends	`DeemedDividends`	-	USD	Annual
Stock consideration for the MicaSense Acquisition	`StockConsiderationForMicasenseAcquisition`	-	USD	Annual
Stock consideration for the MicaSense Acquisition	`StockConsiderationForMicasenseAcquisition`	$3.00M	USD	Annual
Stock consideration for the Measure Acquisition	`StockConsiderationForMeasureAcquisition`	-	USD	Annual
Stock consideration for the Measure Acquisition	`StockConsiderationForMeasureAcquisition`	$24.38M	USD	Annual

Stockholders Equity 30 line items

Line Item	Tag	Value	Unit	Period
Balance as of December 31, 2020	`StockholdersEquity`	$26.35M	USD	Point-in-time
Balance as of December 31, 2020	`StockholdersEquity`	$76.58M	USD	Point-in-time
Balance as of December 31, 2020	`StockholdersEquity`	$4.27M	USD	Point-in-time
Reversal of escrow shares related to Agribotix acquisition	`ReverseSharesIssuedOnPurchaseOfAgribotixAcquisition`	-	USD	Annual
Issuance of Common Stock for consulting services	`StockIssuedDuringPeriodValueIssuedForServices`	$297.50K	USD	Annual
Conversion of Series C Preferred Stock	`SaleOfSeriesCPreferredStock`	-	USD	Annual
Conversion of Series D Preferred stock and accrued dividends	`ConversionOfSeriesDPreferredStockAndAccruedDividends`	$163.56K	USD	Annual
Issuance of Series E Preferred Stock, net of issuance costs	`IssuanceOfSeriesEPreferredStockNetOfIssuanceCosts`	$1.01M	USD	Annual
Repurchase of Series E Preferred Stock	`RepurchaseOfSeriesEPreferredStock1`	$-1.11M	USD	Annual
Conversion of Series E Preferred Stock	`ConversionOfSeriesEPreferredStock`	-	USD	Annual
Sale of Common Stock, net of issuance costs	`SaleOfCommonStockNetOfIssuanceCosts`	$37.18M	USD	Annual
Sale of Common Stock, net of issuance costs	`SaleOfCommonStockNetOfIssuanceCosts`	$22.80M	USD	Annual
Sales of Common stock from exercise of warrants	`SaleOfCommonStockFromConversionOfWarrants`	$3.32M	USD	Annual
Sales of Common stock from exercise of warrants	`SaleOfCommonStockFromConversionOfWarrants`	$8.31M	USD	Annual
Issuance of Common Stock for acquisition of MicaSense	`IssuanceOfCommonStockForAcquisitionOfMicasense`	$3.00M	USD	Annual
Issuance of Common Stock for acquisition of Measure	`IssuanceOfCommonStockForAcquisitionOfMeasure`	$24.38M	USD	Annual
Issuance of Common stock in exchange for professional services	`IssuanceOfCommonStockInExchangeForProfessionalServicesValue`	$2.91M	USD	Annual
Common stock issued upon exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$134.51K	USD	Annual
Common stock issued upon exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$122.97K	USD	Annual
Deemed dividend on Series C Preferred Stock and Series D warrants	`DeemedDividendOnSeriesCPreferredStockAndSeriesDWarrants`	-	USD	Annual
Deemed dividend on redemption of Series D Preferred Stock	`DeemedDividendOnRedemptionOfSeriesDPreferredStock`	-	USD	Annual
Stock-based compensation expense	`StockIssuedDuringPeriodValueShareBasedCompensation`	$402.00K	USD	Annual
Stock-based compensation expense	`StockIssuedDuringPeriodValueShareBasedCompensation`	$4.51M	USD	Annual
Defined benefit plan obligation adjustment, net of tax	`DefinedBenefitPlanObligationAdjustmentNetOfTaxValue`	$-67.90K	USD	Annual
Currency translation adjustment	`ForeignCurrencyTransactionLossBeforeTax`	$2.69K	USD	Annual
Net loss	`NetIncomeLoss`	$-4.93M	USD	Annual
Net loss	`NetIncomeLoss`	$-30.11M	USD	Annual
Ending balance, value	`StockholdersEquity`	$26.35M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$76.58M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$4.27M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.